The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH
Journal of Thrombosis and Haemostasis , Volume 18 - Issue 2 p. 278- 284
Venous thromboembolism is a common complication of asparaginase-based chemotherapy regimens for the treatment of acute lymphoblastic leukemia. Thrombosis associated with asparaginase administration poses a number of specific and often clinically challenging management decisions. This review provides guidance on the prevention and treatment of thrombosis associated with asparaginase in adults including discussions on antithrombin repletion, pharmacologic thromboprophylaxis, cerebral venous thrombosis, and therapeutic anticoagulation.
|Keywords||acute lymphoblastic leukemia, anticoagulation, antithrombin, asparaginase, cerebral venous thrombosis, venous thromboembolism|
|Persistent URL||dx.doi.org/10.1111/jth.14671, hdl.handle.net/1765/124336|
|Journal||Journal of Thrombosis and Haemostasis|
|Organisation||Department of Hematology|
Zwicker, J.I. (Jeffrey I.), Wang, T.-F. (Tzu-Fei), DeAngelo, D.J. (Daniel J.), Lauw, I, Connors, J.M. (Jean M.), Falanga, A. (Anna), … Carrier, M. (Marc). (2020). The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. Journal of Thrombosis and Haemostasis, 18(2), 278–284. doi:10.1111/jth.14671